Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)NMR Structure - model 1
(-)NMR Structure - all models
collapse expand < >
Image NMR Structure - model 1
NMR Structure - model 1  (Jmol Viewer)
Image NMR Structure - all models
NMR Structure - all models  (Jmol Viewer)

(-) Description

Title :  SOLUTION STRUCTURE OF THE RELAXIN-LIKE FACTOR
 
Authors :  E. E. Bullesbach, M. A. S. Hass, M. R. Jensen, D. F. Hansen, S. M. Kristensen, C. Schwabe, J. J. Led
Date :  23 Jul 08  (Deposition) - 16 Dec 08  (Release) - 30 Dec 08  (Revision)
Method :  SOLUTION NMR
Resolution :  NOT APPLICABLE
Chains :  NMR Structure  :  A,B  (20x)
Keywords :  Protein, Cleavage On Pair Of Basic Residues, Disease Mutation, Hormone, Polymorphism, Secreted (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  E. E. Bullesbach, M. A. S. Hass, M. R. Jensen, D. F. Hansen, S. M. Kristensen, C. Schwabe, J. J. Led
Solution Structure Of A Conformationally Restricted Fully Active Derivative Of The Human Relaxin-Like Factor
Biochemistry V. 47 13308 2008
PubMed-ID: 19086273  |  Reference-DOI: 10.1021/BI801412W
(for further references see the PDB file header)

(-) Compounds

Molecule 1 - INSULIN-LIKE 3 A CHAIN
    ChainsA
    EngineeredYES
    FragmentUNP RESIDUES 106-131
    Other DetailsTHIS SEQUENCE OCCURS NATURALLY IN HUMANS.
    SynonymLEYDIG INSULIN-LIKE PEPTIDE, LEY-I-L, RELAXIN- LIKE FACTOR, RLF
    SyntheticYES
 
Molecule 2 - INSULIN-LIKE 3 B CHAIN
    ChainsB
    EngineeredYES
    FragmentUNP RESIDUES 25-55
    Other DetailsTHIS SEQUENCE OCCURS NATURALLY IN HUMANS.
    SynonymLEYDIG INSULIN-LIKE PEPTIDE, LEY-I-L, RELAXIN- LIKE FACTOR, RLF
    SyntheticYES

 Structural Features

(-) Chains, Units

  
NMR Structure (20x)

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (0, 0)

(no "Ligand,Modified Residues,Ions" information available for 2K6T)

(-) Sites  (0, 0)

(no "Site" information available for 2K6T)

(-) SS Bonds  (3, 3)

NMR Structure
No.Residues
1A:115 -A:120
2A:116 -B:34
3A:129 -B:46

(-) Cis Peptide Bonds  (0, 0)

(no "Cis Peptide Bond" information available for 2K6T)

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (3, 3)

NMR Structure (3, 3)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_013232V43LINSL3_HUMANPolymorphism  ---BV43L
2UniProtVAR_013233P49SINSL3_HUMANPolymorphism751299877BP49S
3UniProtVAR_017122N110KINSL3_HUMANDisease (CRYPTO)121912555AN110K

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (1, 1)

NMR Structure (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1INSULINPS00262 Insulin family signature.INSL3_HUMAN115-129  1A:115-129

(-) Exons   (2, 2)

NMR Structure (2, 2)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1ENST000003173061ENSE00001320565chr19:17932325-17932126200INSL3_HUMAN1-64641-
B:25-55
-
31
1.3ENST000003173063ENSE00001639678chr19:17927868-17927324545INSL3_HUMAN64-131681A:106-131
-
26
-

(-) Sequences/Alignments

NMR Structure
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:26
 aligned with INSL3_HUMAN | P51460 from UniProtKB/Swiss-Prot  Length:131

    Alignment length:26
                                   115       125      
          INSL3_HUMAN   106 AAATNPARYCCLSGCTQQDLLTLCPY 131
               SCOP domains -------------------------- SCOP domains
               CATH domains -------------------------- CATH domains
               Pfam domains -------------------------- Pfam domains
         Sec.struct. author ....hhhhhhhhh..hhhhhhhhh.. Sec.struct. author
                 SAPs(SNPs) ----K--------------------- SAPs(SNPs)
                    PROSITE ---------INSULIN        -- PROSITE
           Transcript 1 (1) -------------------------- Transcript 1 (1)
           Transcript 1 (2) Exon 1.3  PDB: A:106-131   Transcript 1 (2)
                 2k6t A 106 AAATNPARYCCLSGCTQQDLLTLCPY 131
                                   115       125      

Chain B from PDB  Type:PROTEIN  Length:31
 aligned with INSL3_HUMAN | P51460 from UniProtKB/Swiss-Prot  Length:131

    Alignment length:31
                                    34        44        54 
          INSL3_HUMAN    25 PTPEMREKLCGHHFVRALVRVCGGPRWSTEA  55
               SCOP domains ------------------------------- SCOP domains
               CATH domains ------------------------------- CATH domains
               Pfam domains ------------------------------- Pfam domains
         Sec.struct. author ..........hhhhhhhhhhhh......... Sec.struct. author
                 SAPs(SNPs) ------------------L-----S------ SAPs(SNPs)
                    PROSITE ------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1  PDB: B:25-55          Transcript 1 (1)
           Transcript 1 (2) ------------------------------- Transcript 1 (2)
                 2k6t B  25 PTPEMREKLCGHHFVRALVRVCGGPRWSTEA  55
                                    34        44        54 

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (0, 0)

(no "SCOP Domain" information available for 2K6T)

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 2K6T)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 2K6T)

(-) Gene Ontology  (19, 19)

NMR Structure(hide GO term definitions)
Chain A,B   (INSL3_HUMAN | P51460)
molecular function
    GO:0001664    G-protein coupled receptor binding    Interacting selectively and non-covalently with a G-protein coupled receptor.
    GO:0005179    hormone activity    The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
    GO:0005158    insulin receptor binding    Interacting selectively and non-covalently with the insulin receptor.
    GO:0002020    protease binding    Interacting selectively and non-covalently with any protease or peptidase.
    GO:0005102    receptor binding    Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
biological process
    GO:0007193    adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway    The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds through inhibition of adenylyl cyclase activity and a subsequent decrease in the concentration of cyclic AMP (cAMP).
    GO:0007267    cell-cell signaling    Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
    GO:0008584    male gonad development    The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
    GO:0043066    negative regulation of apoptotic process    Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
    GO:0008285    negative regulation of cell proliferation    Any process that stops, prevents or reduces the rate or extent of cell proliferation.
    GO:0001556    oocyte maturation    A developmental process, independent of morphogenetic (shape) change, that is required for an oocyte to attain its fully functional state. Oocyte maturation commences after reinitiation of meiosis commonly starting with germinal vesicle breakdown, and continues up to the second meiotic arrest prior to fertilization.
    GO:0030819    positive regulation of cAMP biosynthetic process    Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0010634    positive regulation of epithelial cell migration    Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
    GO:0090303    positive regulation of wound healing    Any process that increases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.
    GO:0007283    spermatogenesis    The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
cellular component
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0048471    perinuclear region of cytoplasm    Cytoplasm situated near, or occurring around, the nucleus.

 Visualization

(-) Interactive Views

NMR Structure
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
(no "Ligands, Modified Residues, Ions" information available for 2k6t)
 
  Sites
(no "Sites" information available for 2k6t)
 
  Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 2k6t)
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2k6t
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  INSL3_HUMAN | P51460
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  219050
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  INSL3_HUMAN | P51460
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        INSL3_HUMAN | P514602h8b 2k6u

(-) Related Entries Specified in the PDB File

2h8b INDEPENDENT STRUCTURE ASSIGNMENT
2k6u CROSS-LINKED DERIVATIVE DETERMINE UNDER THE SAME EXPERIMENTAL CONDITIONS